Tenax Therapeutics Inc
NASDAQ:TENX

Watchlist Manager
Tenax Therapeutics Inc Logo
Tenax Therapeutics Inc
NASDAQ:TENX
Watchlist
Price: 5.82 USD 4.45%
Market Cap: 24.2m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of TENX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TENX Intrinsic Value
Not Available
Base Case Scenario

Fundamental Analysis

Tenax Therapeutics Inc
NASDAQ:TENX
US
Biotechnology
Market Cap
24.2m USD
IPO
Oct 28, 1993
US
Biotechnology
Market Cap
24.2m USD
IPO
Oct 28, 1993
Price
$false
EPS
$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Tenax Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tenax Therapeutics Inc

Current Assets 96.7m
Cash & Short-Term Investments 94.9m
Other Current Assets 1.8m
Efficiency

Free Cash Flow Analysis
Tenax Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tenax Therapeutics Inc

Revenue
0 USD
Operating Expenses
-19.5m USD
Operating Income
-19.5m USD
Other Expenses
1.9m USD
Net Income
-17.6m USD
Fundamental Scores

TENX Profitability Score
Profitability Due Diligence

Tenax Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

33/100
Profitability
Score

Tenax Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

TENX Solvency Score
Solvency Due Diligence

Tenax Therapeutics Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
49/100
Solvency
Score

Tenax Therapeutics Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TENX Price Targets Summary
Tenax Therapeutics Inc

Wall Street analysts forecast TENX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TENX is 22.44 USD with a low forecast of 16.16 USD and a high forecast of 31.5 USD.

Lowest
Price Target
16.16 USD
178% Upside
Average
Price Target
22.44 USD
286% Upside
Highest
Price Target
31.5 USD
441% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Tenax Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TENX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TENX Insider Trading
Buy and sell transactions by insiders